HYPERBARIC CHAMBER TEST - AN OVERVIEW

Watch Comprehensive Prescribing Details OPDIVO® (nivolumab) is indicated with the treatment of adult patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed immediately after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin or right after three or even more strains of systemic therapy that fe